UroGen Pharma Ltd.
NASDAQ:URGN
12.12 (USD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||
| Current Assets: | |||||||||||
| Cash & Cash Equivalents
| 95.823 | 55.408 | 44.36 | 103.911 | 49.688 | 101.318 | 36.999 | 21.362 | 17.975 | 3.87 | 3.037 |
| Short Term Investments
| 41.966 | 44.556 | 44.779 | 49.154 | 97.389 | 0 | 36.001 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 137.789 | 99.963 | 89.814 | 103.911 | 147.077 | 101.318 | 73 | 21.362 | 17.975 | 3.87 | 3.037 |
| Net Receivables
| 15.443 | 12.704 | 11.717 | 7.047 | 0 | 0 | 0.198 | 0.083 | 0 | 0 | 0 |
| Inventory
| 5.673 | 4.325 | 4.832 | 1.964 | 0 | 0 | 0.316 | 0.105 | 0 | 0 | 0 |
| Other Current Assets
| 10.281 | 11.101 | 7.476 | 3.364 | 1.034 | 0.672 | 0.958 | 0.396 | 1.135 | 0.418 | 0.111 |
| Total Current Assets
| 169.186 | 128.907 | 114.39 | 115.619 | 148.634 | 102.243 | 74.472 | 22.041 | 19.131 | 4.288 | 3.148 |
| Non-Current Assets: | |||||||||||
| Property, Plant & Equipment, Net
| 2.36 | 3.749 | 3.147 | 4.204 | 4.712 | 0.948 | 0.805 | 0.741 | 0.259 | 0.071 | 0.077 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 4.727 | 0.223 | 0.675 | 1.893 | 48.555 | 0.051 | 0.029 | 0.024 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 2.038 | 2.74 | 1.534 | 0.289 | 0.487 | 0.317 | 0.244 | 0.25 | 0 | 0 | 0 |
| Total Non-Current Assets
| 9.125 | 6.712 | 5.356 | 6.386 | 53.754 | 1.316 | 1.078 | 1.015 | 0.259 | 0.071 | 0.077 |
| Total Assets
| 178.311 | 136.239 | 119.746 | 122.005 | 202.388 | 103.559 | 75.55 | 23.056 | 19.39 | 4.359 | 3.225 |
| Liabilities & Equity: | |||||||||||
| Current Liabilities: | |||||||||||
| Account Payables
| 6.514 | 5.527 | 5.786 | 3.271 | 4.694 | 8.54 | 4.435 | 1.88 | 1.728 | 0.513 | 0.334 |
| Short Term Debt
| 0.819 | 0.941 | 3.33 | 1.859 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 4.391 | 0.618 | 0.497 | 0.382 | 0 | 0 | 0.65 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 19.488 | 16.83 | 12.767 | 15.924 | 14.788 | 4.925 | 1.95 | 1.257 | 0.509 | 0.378 | 0.15 |
| Total Current Liabilities
| 31.212 | 23.916 | 22.38 | 21.436 | 19.482 | 13.465 | 7.035 | 3.137 | 2.237 | 0.891 | 0.484 |
| Non-Current Liabilities: | |||||||||||
| Long Term Debt
| 98.551 | 99.123 | 0.398 | 1.497 | 2.604 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | -2.842 | -2.717 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 3.018 | 2.842 | 2.717 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 113.76 | 98.923 | 88.555 | 2.717 | 0 | 0 | 0 | 3.612 | 0.872 | 0 | 0 |
| Total Non-Current Liabilities
| 212.311 | 201.064 | 88.953 | 4.214 | 2.604 | 0 | 0 | 3.612 | 0.872 | 0 | 0 |
| Total Liabilities
| 243.523 | 224.98 | 111.333 | 25.65 | 22.086 | 13.465 | 7.035 | 6.749 | 3.109 | 0.891 | 0.484 |
| Equity: | |||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.013 | 0.013 | 0.306 | 0 |
| Common Stock
| 0.089 | 0.063 | 0.061 | 0.06 | 0.057 | 0.044 | 0.037 | 0.006 | 0.006 | 0.002 | 0.002 |
| Retained Earnings
| -679.348 | -577.104 | -467.321 | -356.501 | -228.017 | -122.871 | -47.214 | -27.214 | -25.273 | -12.584 | -8.108 |
| Accumulated Other Comprehensive Income/Loss
| 0.012 | -0.107 | -0.025 | 0.271 | 0.276 | -0.747 | -0.577 | -0.37 | -0.157 | 0 | 0 |
| Other Total Stockholders Equity
| 614.035 | 488.407 | 475.698 | 452.525 | 407.986 | 213.668 | 116.269 | 43.872 | 41.692 | 15.744 | 10.847 |
| Total Shareholders Equity
| -65.212 | -88.741 | 8.413 | 96.355 | 180.302 | 90.094 | 68.515 | 16.307 | 16.281 | 3.468 | 2.741 |
| Total Equity
| -65.212 | -88.741 | 8.413 | 96.355 | 180.302 | 90.094 | 68.515 | 16.307 | 16.281 | 3.468 | 2.741 |
| Total Liabilities & Shareholders Equity
| 178.311 | 136.239 | 119.746 | 122.005 | 202.388 | 103.559 | 75.55 | 23.056 | 19.39 | 4.359 | 3.225 |